156 related articles for article (PubMed ID: 36882838)
21. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
[TBL] [Abstract][Full Text] [Related]
22. Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge.
Goffin V
Pharmacol Ther; 2017 Nov; 179():111-126. PubMed ID: 28549597
[TBL] [Abstract][Full Text] [Related]
23. Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity.
Zhao D; Ma G; Zhang X; He Y; Li M; Han X; Fu L; Dong XY; Nagy T; Zhao Q; Fu L; Dong JT
J Biol Chem; 2016 Jun; 291(24):12809-12820. PubMed ID: 27129249
[TBL] [Abstract][Full Text] [Related]
24. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
[TBL] [Abstract][Full Text] [Related]
25. Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.
Barcus CE; O'Leary KA; Brockman JL; Rugowski DE; Liu Y; Garcia N; Yu M; Keely PJ; Eliceiri KW; Schuler LA
Breast Cancer Res; 2017 Jan; 19(1):9. PubMed ID: 28103936
[TBL] [Abstract][Full Text] [Related]
26. Inclusion of Plasma Prolactin Levels in Current Risk Prediction Models of Premenopausal and Postmenopausal Breast Cancer.
Gabrielson M; Ubhayasekera K; Ek B; Andersson Franko M; Eriksson M; Czene K; Bergquist J; Hall P
JNCI Cancer Spectr; 2018 Oct; 2(4):pky055. PubMed ID: 31360875
[TBL] [Abstract][Full Text] [Related]
27. Bioactive prolactin levels and risk of breast cancer: a nested case-control study.
Tworoger SS; Rice MS; Rosner BA; Feeney YB; Clevenger CV; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):73-80. PubMed ID: 25315962
[TBL] [Abstract][Full Text] [Related]
28. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex.
Xu J; Zhang Y; Berry PA; Jiang J; Lobie PE; Langenheim JF; Chen WY; Frank SJ
Mol Endocrinol; 2011 Apr; 25(4):597-610. PubMed ID: 21310852
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of prolactin receptor expression in breast cancer subtypes].
Kalinina TS; Kononchuk VV; Sidorov SV; Gulyaeva LF
Biomed Khim; 2020 Jan; 66(1):89-94. PubMed ID: 32116231
[TBL] [Abstract][Full Text] [Related]
30. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
[TBL] [Abstract][Full Text] [Related]
31. Global profiling of prolactin-modulated transcripts in breast cancer in vivo.
Sato T; Tran TH; Peck AR; Liu C; Ertel A; Lin J; Neilson LM; Rui H
Mol Cancer; 2013 Jun; 12():59. PubMed ID: 23758962
[TBL] [Abstract][Full Text] [Related]
32. A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development.
Tworoger SS; Eliassen AH; Zhang X; Qian J; Sluss PM; Rosner BA; Hankinson SE
Cancer Res; 2013 Aug; 73(15):4810-9. PubMed ID: 23783576
[TBL] [Abstract][Full Text] [Related]
33. Seasonal expressions of prolactin, prolactin receptor and STAT5 in the scented glands of the male muskrats (Ondatra zibethicus).
Xie W; Liu H; Liu Q; Gao Q; Gao F; Han Y; Yuan Z; Zhang H; Weng Q
Eur J Histochem; 2019 Jan; 63(1):. PubMed ID: 30652434
[TBL] [Abstract][Full Text] [Related]
34. Cells with minimal expression of the JAK/STAT pathway related proteins STAT5a and the prolactin receptor: evidence of an alternate prolactin receptor isoform in breast disease.
Bratthauer GL; Stamatakos MD; Vinh TN
Protein Pept Lett; 2010 Jan; 17(1):104-8. PubMed ID: 20214633
[TBL] [Abstract][Full Text] [Related]
35. Serum Prolactin Contributes to Enhancing Prolactin Receptor and pJAK2 in Type I Endometrial Cancer Cells in Young Women Without Insulin Resistance.
Erdenebaatar C; Yamaguchi M; Monsur M; Saito F; Honda R; Tashiro H; Ohba T; Iyama KI; Katabuchi H
Int J Gynecol Pathol; 2019 Jul; 38(4):318-325. PubMed ID: 29901521
[TBL] [Abstract][Full Text] [Related]
36. CAML promotes prolactin-dependent proliferation of breast cancer cells by facilitating prolactin receptor signaling pathways.
Lim JH; Kim TY; Kim WH; Park JW
Breast Cancer Res Treat; 2011 Nov; 130(1):19-27. PubMed ID: 21128111
[TBL] [Abstract][Full Text] [Related]
37. Prolactin improves hepatic steatosis via CD36 pathway.
Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
[TBL] [Abstract][Full Text] [Related]
38. Connections between prolactin and ovarian cancer.
Alkharusi A; AlMuslahi A; AlBalushi N; AlAjmi R; AlRawahi S; AlFarqani A; Norstedt G; Zadjali F
PLoS One; 2021; 16(8):e0255701. PubMed ID: 34358244
[TBL] [Abstract][Full Text] [Related]
39. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women.
Hankinson SE; Willett WC; Michaud DS; Manson JE; Colditz GA; Longcope C; Rosner B; Speizer FE
J Natl Cancer Inst; 1999 Apr; 91(7):629-34. PubMed ID: 10203283
[TBL] [Abstract][Full Text] [Related]
40. Plasma prolactin and breast cancer risk: a meta- analysis.
Wang M; Wu X; Chai F; Zhang Y; Jiang J
Sci Rep; 2016 May; 6():25998. PubMed ID: 27184120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
